A detailed history of Wolverine Asset Management LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 3,555 shares of RVPH stock, worth $4,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,555
Previous 4,530 21.52%
Holding current value
$4,017
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$0.64 - $1.48 $624 - $1,443
-975 Reduced 21.52%
3,555 $5,000
Q2 2024

Aug 01, 2024

BUY
$1.25 - $3.79 $1,443 - $4,377
1,155 Added 34.22%
4,530 $5,000
Q1 2024

May 13, 2024

SELL
$2.76 - $5.52 $3,516 - $7,032
-1,274 Reduced 27.4%
3,375 $12,000
Q4 2023

Feb 01, 2024

SELL
$3.56 - $6.04 $33,289 - $56,480
-9,351 Reduced 66.79%
4,649 $23,000
Q3 2023

Nov 13, 2023

SELL
$3.91 - $5.9 $1,958 - $2,955
-501 Reduced 3.45%
14,000 $68,000
Q2 2023

Aug 07, 2023

BUY
$4.42 - $8.55 $37,114 - $71,794
8,397 Added 137.57%
14,501 $84,000
Q1 2023

May 08, 2023

SELL
$3.79 - $4.87 $2,690 - $3,457
-710 Reduced 10.42%
6,104 $25,000
Q4 2022

Feb 01, 2023

BUY
$1.68 - $5.99 $10,340 - $36,868
6,155 Added 933.99%
6,814 $28,000
Q1 2022

May 04, 2022

BUY
$1.61 - $3.01 $776 - $1,450
482 Added 272.32%
659 $1,000
Q4 2021

Feb 09, 2022

BUY
$2.7 - $4.23 $477 - $748
177 New
177 $0
Q2 2021

Aug 13, 2021

SELL
$4.05 - $8.7 $12,465 - $26,778
-3,078 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$5.4 - $9.49 $16,621 - $29,210
3,078 New
3,078 $17,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $23.1M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.